Literature DB >> 13525583

The development in vitro of particles from cytoplasm. I. Observations on particle development in bacteriologic media.

E L NELSON.   

Abstract

A system is described in which microscopically visible particles develop from cytoplasmic proteins incubated in vitro. The conditions required for the development of particles are those usually associated with enzymic reactions. The particles are believed to develop as a result of enzyme action on cytoplasmic proteins in the presence of compounds having certain specific chemical configurations. The relation of the particles to various "microorganisms," described in the literature as etiologic agents of disease, and to the problem of seemingly positive blood cultures is discussed.

Keywords:  PROTOPLASM

Mesh:

Year:  1958        PMID: 13525583      PMCID: PMC2136850          DOI: 10.1084/jem.107.5.755

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  T-Form colonies of pleuropneumonialike organisms.

Authors:  M C SHEPARD
Journal:  J Bacteriol       Date:  1956-03       Impact factor: 3.490

2.  Oxidation of phenylhydrazines in the presence of oxyhaemoglobin and the origin of Heinz bodies in erythrocytes.

Authors:  G H BEAVEN; J C WHITE
Journal:  Nature       Date:  1954-02-27       Impact factor: 49.962

3.  The recovery of L forms of Brucella and their relation to Brucella phage.

Authors:  E L NELSON; M J PICKETT
Journal:  J Infect Dis       Date:  1951 Nov-Dec       Impact factor: 5.226

4.  Observations on the problem of Brucella blood cultures.

Authors:  M J PICKETT; E L NELSON
Journal:  J Bacteriol       Date:  1951-02       Impact factor: 3.490

  4 in total
  2 in total

Review 1.  Bacterial persistence and expression of disease.

Authors:  G J Domingue; H B Woody
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

2.  The development in vitro of particles from cytoplasm. II. Particles from hemoglobin and deoxyribonucleic acid.

Authors:  E L NELSON
Journal:  J Exp Med       Date:  1958-05-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.